MARKET

TRIB

TRIB

Trinity Biotech Plc
NASDAQ
1.690
+0.060
+3.68%
After Hours: 1.610 -0.08 -4.73% 16:00 05/24 EDT
OPEN
1.620
PREV CLOSE
1.630
HIGH
1.700
LOW
1.580
VOLUME
5.88K
TURNOVER
0
52 WEEK HIGH
5.50
52 WEEK LOW
1.490
MARKET CAP
16.00M
P/E (TTM)
-0.5386
1D
5D
1M
3M
1Y
5Y
TRIB Stock Earnings: Trinity Biotech Reported Results for Q1 2024
Trinity Biotech just reported results for the first quarter of 2024. The company reported earnings per share of -37 cents. Trinity Biotech reported revenue of $ million. The company has a market value of $1.2 billion. The stock was down 0.7% in the afternoon.
Investorplace · 3d ago
Trinity Biotech GAAP EPADS of -$0.37, revenue of $14.7M
Trinity Biotech plc has a Q1 GAAP EPADS of -$ and revenue of $ The Group's cash balance increased from $ at the end of Q4, 2024 to $ in Q1, 2024. Trinity Biotech stock is down 1.7% in the last month.
Seeking Alpha · 3d ago
TRINITY BIOTECH PLC - BASIC LOSS PER ADS FOR Q1, 2024 WAS $0.37
Reuters · 3d ago
Notable earnings before Thursday's open
Seeking Alpha · 4d ago
Trinity Biotech plc to Announce Q1 2024 Financial Results
Trinity Biotech plc will report financial results for the first quarter 2024 on Thursday, May 23, 2024 at 8:30am ET. The company is a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics. Trinity Biotech is a company in Ireland.
Barchart · 5d ago
Weekly Report: what happened at TRIB last week (0513-0517)?
Weekly Report · 6d ago
Earnings week ahead: NVIDIA, Target, Zoom Video, Snowflake and more
Seeking Alpha · 05/19 12:02
Trinity Biotech Announces Strategic Collaboration With Medical AI Co. PulseAI
NASDAQ · 05/16 18:20
More
About TRIB
Trinity Biotech PLC is an Ireland-based develops, acquires, manufactures and markets medical diagnostic systems, including both reagents and instrumentation for the clinical laboratory and point-of-care segments of the diagnostic market. The Company's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. Its segments include the Americas and Rest of World. It is a provider of raw materials to the life sciences and research industries globally. It also operates a licensed reference laboratory that specializes in diagnostics for autoimmune diseases. Its POC brands include Uni-Gold, Recombigen, MarDx, FlexTrans, Premier and Ultra. Its clinical laboratory brands include ImmuBlot, ImmuGlo, ImmuLisa, OTOblot and EZ. The Company manufactures kits for the detection of specialty and esoteric biomarkers of infectious diseases and other associated laboratory products.

Webull offers Trinity Biotech plc (ADR) stock information, including NASDAQ: TRIB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TRIB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TRIB stock methods without spending real money on the virtual paper trading platform.